N4 Pharma Plc (FRA:0GO)
0.0010
0.00 (0.00%)
At close: Jan 2, 2026
N4 Pharma Market Cap
N4 Pharma has a market cap or net worth of €4.8 million as of January 9, 2026. Its market cap has increased by 91.67% in one year.
Market Cap
4.80M
Enterprise Value
2.81M
Revenue
8.24K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.00
Market Cap Chart
Since May 3, 2017, N4 Pharma's market cap has decreased from 5.41M to 4.80M, a decrease of -11.27%. That is a compound annual growth rate of -1.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 4.80M | -4.25% |
| Dec 31, 2025 | 5.01M | 99.85% |
| Dec 31, 2024 | 2.51M | -4.80% |
| Dec 29, 2023 | 2.63M | -46.01% |
| Dec 30, 2022 | 4.88M | -49.18% |
| Dec 31, 2021 | 9.59M | -43.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |